Jun 13 |
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
|
May 29 |
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
|
May 15 |
PLX: First Quarter Update
|
May 13 |
Protalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
May 11 |
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript
|
May 10 |
Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript
|
May 10 |
Protalix BioTherapeutics GAAP EPS of -$0.06 misses by $0.04, revenue of $3.75M
|
May 10 |
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
|
May 9 |
Protalix BioTherapeutics Q1 Earnings Preview
|
May 3 |
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
|